| Bacillus anthracis |
Anthrax lethal factor |
Potency |
15848.9 |
nM |
None |
| Bos taurus |
Progesterone receptor |
IC50 |
nan |
None |
None |
| Bos taurus |
Progesterone receptor |
Ki |
nan |
None |
None |
| Bos taurus |
Synaptic vesicular amine transporter |
Ki |
1.0 |
nM |
10.1021/jm070875p |
| Cavia porcellus |
Leukotriene C4 synthase |
IC50 |
nan |
None |
None |
| Cavia porcellus |
Leukotriene C4 synthase |
Ki |
nan |
None |
None |
| Cavia porcellus |
Serotonin 4 (5-HT4) receptor |
IC50 |
nan |
None |
None |
| Cavia porcellus |
Serotonin 4 (5-HT4) receptor |
Ki |
nan |
None |
None |
| Chlorocebus sabaeus |
Vero C1008 |
CC50 |
25000.0 |
nM |
10.1021/acs.jmedchem.0c00626 |
| Cryptosporidium parvum |
Cryptosporidium parvum |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Drosophila |
Drosophila |
Activity |
25.0 |
% |
10.1038/nchembio.78 |
| Electrophorus electricus |
Acetylcholinesterase |
Inhibition |
5.06 |
% |
10.1016/j.bmc.2012.09.040 |
| Entamoeba histolytica |
Entamoeba histolytica |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Equus caballus |
Cholinesterase |
Inhibition |
15.34 |
% |
10.1016/j.bmc.2012.09.040 |
| Escherichia coli |
Escherichia coli |
MIC |
62.0 |
ug.mL-1 |
10.1128/aac.00580-10 |
| Escherichia coli |
Escherichia coli |
MIC |
128.0 |
ug.mL-1 |
10.1128/aac.01048-06 |
| Escherichia coli |
Escherichia coli |
MIC |
256.0 |
ug.mL-1 |
10.1128/aac.01048-06 |
| Escherichia coli K-12 |
Endonuclease 4 |
Potency |
6309.6 |
nM |
None |
| Homo sapiens |
786-0 |
GI50 |
14157.94 |
nM |
None |
| Homo sapiens |
A549 |
GI50 |
17988.71 |
nM |
None |
| Homo sapiens |
Acetylcholinesterase |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Acetylcholinesterase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Acetylcholinesterase |
Ki |
nan |
None |
None |
| Homo sapiens |
ACHN |
GI50 |
15031.42 |
nM |
None |
| Homo sapiens |
Adenosine A1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Adenosine A2a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A2a receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A2a receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
17678.7 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
26500.3 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Adenosine A3 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Aldehyde dehydrogenase 1A1 |
Potency |
19952.6 |
nM |
None |
| Homo sapiens |
Aldehyde dehydrogenase 1A1 |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
12000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1d adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-1d adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-2a adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-2b adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2b adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-2b adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Alpha-2c adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2c adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Alpha-2c adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Androgen Receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Androgen Receptor |
Potency |
22387.2 |
nM |
None |
| Homo sapiens |
Androgen Receptor |
Potency |
28183.8 |
nM |
None |
| Homo sapiens |
Angiotensin II type 2 (AT-2) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Angiotensin II type 2 (AT-2) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Arachidonate 15-lipoxygenase |
Potency |
19952.6 |
nM |
None |
| Homo sapiens |
ATPase family AAA domain-containing protein 5 |
Potency |
10000.0 |
nM |
None |
| Homo sapiens |
ATPase family AAA domain-containing protein 5 |
Potency |
11577.4 |
nM |
None |
| Homo sapiens |
ATP-binding cassette sub-family G member 2 |
IC50 |
11800.0 |
nM |
10.1016/j.ejmech.2022.114346 |
| Homo sapiens |
ATP-binding cassette sub-family G member 2 |
IC50 |
12600.0 |
nM |
10.1016/j.ejmech.2017.06.047 |
| Homo sapiens |
ATP-binding cassette sub-family G member 2 |
IC50 |
26302.68 |
nM |
10.1016/j.bmc.2008.07.034 |
| Homo sapiens |
Beta-1 adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-1 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-1 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Beta-2 adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-2 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-2 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Beta-3 adrenergic receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Beta-3 adrenergic receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Bile acid receptor FXR |
Potency |
2511.9 |
nM |
None |
| Homo sapiens |
Bile acid receptor FXR |
Potency |
25118.9 |
nM |
None |
| Homo sapiens |
Bile salt export pump |
Activity |
nan |
None |
10.1023/a:1023278211849 |
| Homo sapiens |
Bile salt export pump |
IC50 |
8350.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Bile salt export pump |
IC50 |
8400.0 |
nM |
10.1021/acs.jmedchem.0c00524 |
| Homo sapiens |
Bile salt export pump |
IC50 |
8400.0 |
nM |
10.1093/toxsci/kfq269 |
| Homo sapiens |
Bile salt export pump |
IC50 |
10000.0 |
nM |
10.1124/dmd.112.047068 |
| Homo sapiens |
Bile salt export pump |
IC50 |
10200.0 |
nM |
10.1023/a:1023278211849 |
| Homo sapiens |
Bloom syndrome protein |
Potency |
17782.8 |
nM |
None |
| Homo sapiens |
Bradykinin B2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bradykinin B2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Bradykinin B2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Bromodomain adjacent to zinc finger domain protein 2B |
Potency |
28183.8 |
nM |
None |
| Homo sapiens |
CAKI-1 |
GI50 |
18113.4 |
nM |
None |
| Homo sapiens |
Calcitonin receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Calcitonin receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Canalicular multispecific organic anion transporter 1 |
Activity |
37.0 |
% |
10.1021/jm7015683 |
| Homo sapiens |
Canalicular multispecific organic anion transporter 1 |
IC50 |
68400.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Canalicular multispecific organic anion transporter 1 |
Ki |
295000.0 |
nM |
10.1023/a:1016192413308 |
| Homo sapiens |
Canalicular multispecific organic anion transporter 2 |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Cannabinoid CB1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cannabinoid CB1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cannabinoid CB1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Carbonic anhydrase II |
IC50 |
nan |
None |
None |
| Homo sapiens |
Carbonic anhydrase II |
Ki |
nan |
None |
None |
| Homo sapiens |
Caspase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Caspase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Caspase-1 |
Potency |
7943.3 |
nM |
None |
| Homo sapiens |
Caspase-7 |
Potency |
7943.3 |
nM |
None |
| Homo sapiens |
Cathepsin G |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cathepsin G |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 2 |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 4 |
Ki |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
C-C chemokine receptor type 5 |
Ki |
nan |
None |
None |
| Homo sapiens |
CCRF-CEM |
GI50 |
13243.42 |
nM |
None |
| Homo sapiens |
Cholecystokinin A receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cholecystokinin A receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cholecystokinin A receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Chromobox protein homolog 1 |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
Chromobox protein homolog 1 |
Potency |
50118.7 |
nM |
None |
| Homo sapiens |
COLO 205 |
GI50 |
15667.51 |
nM |
None |
| Homo sapiens |
Cyclooxygenase-1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cyclooxygenase-2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cysteinyl leukotriene receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cysteinyl leukotriene receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 1A2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 1A2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2A6 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2A6 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2E1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2E1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
Potency |
3981.1 |
nM |
None |
| Homo sapiens |
Delta opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Delta opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Delta opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
DLD-1 |
GI50 |
30549.21 |
nM |
None |
| Homo sapiens |
DMS-114 |
GI50 |
15559.66 |
nM |
None |
| Homo sapiens |
DMS-273 |
GI50 |
19998.62 |
nM |
None |
| Homo sapiens |
DNA dC->dU-editing enzyme APOBEC-3F |
Potency |
31622.8 |
nM |
None |
| Homo sapiens |
DNA polymerase beta |
Potency |
31622.8 |
nM |
None |
| Homo sapiens |
DNA polymerase eta |
Potency |
7943.3 |
nM |
None |
| Homo sapiens |
DNA polymerase iota |
Potency |
10000.0 |
nM |
None |
| Homo sapiens |
DNA topoisomerase I |
IC50 |
160000.0 |
nM |
10.1021/np058007n |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D3 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine D4 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine D4 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Dopamine transporter |
AC50 |
12999.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
AC50 |
29271.2 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
IC50 |
nan |
None |
None |
| Homo sapiens |
Dopamine transporter |
Ki |
nan |
None |
None |
| Homo sapiens |
Endoplasmic reticulum-associated amyloid beta-peptide-binding protein |
Potency |
25118.9 |
nM |
None |
| Homo sapiens |
Endothelin receptor ET-A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Endothelin receptor ET-A |
Ki |
nan |
None |
None |
| Homo sapiens |
Epidermal growth factor receptor erbB1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Epidermal growth factor receptor erbB1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Equilibrative nucleoside transporter 1 |
AC50 |
28499.7 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor alpha |
Potency |
15848.9 |
nM |
None |
| Homo sapiens |
Estrogen receptor alpha |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
Estrogen receptor beta |
IC50 |
nan |
None |
None |
| Homo sapiens |
Estrogen receptor beta |
Ki |
nan |
None |
None |
| Homo sapiens |
Flap endonuclease 1 |
Potency |
3768.6 |
nM |
None |
| Homo sapiens |
Flap endonuclease 1 |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
Gamma-aminobutyric acid receptor subunit alpha-1/alpha-2/beta-2/gamma-2 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Geminin |
Potency |
11220.2 |
nM |
None |
| Homo sapiens |
Geminin |
Potency |
16360.1 |
nM |
None |
| Homo sapiens |
Geminin |
Potency |
29855.4 |
nM |
None |
| Homo sapiens |
Ghrelin receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucagon-like peptide 1 receptor |
Potency |
28183.8 |
nM |
None |
| Homo sapiens |
Glucocorticoid receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucocorticoid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Glucocorticoid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Glucocorticoid receptor |
Potency |
3.2 |
nM |
None |
| Homo sapiens |
GTP-binding nuclear protein Ran/Importin subunit beta-1/Snurportin-1 |
Potency |
11582.1 |
nM |
None |
| Homo sapiens |
HCC 2998 |
GI50 |
27797.13 |
nM |
None |
| Homo sapiens |
HCT-116 |
GI50 |
13740.42 |
nM |
None |
| Homo sapiens |
HCT-15 |
GI50 |
20276.83 |
nM |
None |
| Homo sapiens |
HEK293 |
Activity |
nan |
None |
10.1021/acs.jmedchem.8b00542 |
| Homo sapiens |
HEK293 |
Potency |
7304.8 |
nM |
None |
| Homo sapiens |
HEK293 |
Potency |
7943.3 |
nM |
None |
| Homo sapiens |
Hemoglobin beta chain |
Potency |
31622.8 |
nM |
None |
| Homo sapiens |
HEp-2 |
ED50 |
20.0 |
ug ml-1 |
10.1021/np800148w |
| Homo sapiens |
HepG2 |
CC50 |
nan |
None |
10.1016/j.ejmech.2018.06.013 |
| Homo sapiens |
HepG2 |
CC50 |
nan |
None |
10.1021/acs.jmedchem.8b00791 |
| Homo sapiens |
HepG2 |
IC50 relative |
11800.0 |
nM |
10.6019/EOS300108 |
| Homo sapiens |
HERG |
AC50 |
1462.4 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
HERG |
IC50 |
nan |
None |
None |
| Homo sapiens |
HERG |
Ki |
nan |
None |
None |
| Homo sapiens |
HERG |
Potency |
794.3 |
nM |
None |
| Homo sapiens |
HERG |
Potency |
5011.9 |
nM |
None |
| Homo sapiens |
Histamine H1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Histamine H1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Histamine H2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Histamine H2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Histamine H3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histone acetyltransferase GCN5 |
Potency |
7079.5 |
nM |
None |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-1.89 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
0.37 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 |
Potency |
2511.9 |
nM |
None |
| Homo sapiens |
Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 |
Potency |
17782.8 |
nM |
None |
| Homo sapiens |
Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 |
Potency |
22387.2 |
nM |
None |
| Homo sapiens |
Histone-lysine N-methyltransferase MLL |
Potency |
28183.8 |
nM |
None |
| Homo sapiens |
HL-60 |
GI50 |
14223.29 |
nM |
None |
| Homo sapiens |
HL-60 |
IC50 |
67000.0 |
nM |
10.1021/np058007n |
| Homo sapiens |
HMG-CoA reductase |
IC50 |
nan |
None |
None |
| Homo sapiens |
HMG-CoA reductase |
Ki |
nan |
None |
None |
| Homo sapiens |
Homo sapiens |
AUC |
8.522 |
ng.hr.mL-1 |
10.1093/toxsci/kft176 |
| Homo sapiens |
Homo sapiens |
Css |
0.001 |
uM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Homo sapiens |
DILI_Concern |
nan |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Homo sapiens |
DILI_severity_class |
0.0 |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Homo sapiens |
Fabs |
50.0 |
% |
10.1124/dmd.110.034629 |
| Homo sapiens |
HOP-62 |
GI50 |
12647.36 |
nM |
None |
| Homo sapiens |
HOP-92 |
GI50 |
10839.27 |
nM |
None |
| Homo sapiens |
HT-29 |
GI50 |
11967.41 |
nM |
None |
| Homo sapiens |
IGROV-1 |
GI50 |
21478.3 |
nM |
None |
| Homo sapiens |
Importin subunit beta-1/Snurportin-1 |
Potency |
44668.4 |
nM |
None |
| Homo sapiens |
Interleukin-8 |
Potency |
66824.2 |
nM |
None |
| Homo sapiens |
Interleukin-8 receptor A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor A |
Ki |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor B |
IC50 |
nan |
None |
None |
| Homo sapiens |
Interleukin-8 receptor B |
Ki |
nan |
None |
None |
| Homo sapiens |
Isocitrate dehydrogenase [NADP] cytoplasmic |
Potency |
32642.7 |
nM |
None |
| Homo sapiens |
K562 |
GI50 |
7112.14 |
nM |
None |
| Homo sapiens |
Kappa opioid receptor |
AC50 |
11710.6 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Kappa opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Kappa opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
KM12 |
GI50 |
18407.72 |
nM |
None |
| Homo sapiens |
KM-20L2 |
GI50 |
16710.91 |
nM |
None |
| Homo sapiens |
Lethal(3)malignant brain tumor-like protein 1 |
Potency |
28183.8 |
nM |
None |
| Homo sapiens |
Leukocyte common antigen |
IC50 |
nan |
None |
None |
| Homo sapiens |
Leukocyte common antigen |
Ki |
nan |
None |
None |
| Homo sapiens |
Leukocyte elastase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Leukocyte elastase |
Ki |
nan |
None |
None |
| Homo sapiens |
Liver microsomes |
CL |
18.3 |
mL.min-1.g-1 |
10.1016/j.bmcl.2011.12.005 |
| Homo sapiens |
LXFL 529 |
GI50 |
14421.15 |
nM |
None |
| Homo sapiens |
Lymphoblastoid cell |
Potency |
31622.8 |
nM |
None |
| Homo sapiens |
Lymphoblastoid cell |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
Lymphoblastoid cell |
Potency |
50118.7 |
nM |
None |
| Homo sapiens |
Lymphoblastoid cell |
Potency |
63095.7 |
nM |
None |
| Homo sapiens |
Lymphoblastoid cell |
Potency |
79432.8 |
nM |
None |
| Homo sapiens |
Lysine-specific demethylase 4A |
Potency |
56234.1 |
nM |
None |
| Homo sapiens |
Lysine-specific demethylase 4D-like |
Potency |
22387.2 |
nM |
None |
| Homo sapiens |
M14 |
GI50 |
15417.0 |
nM |
None |
| Homo sapiens |
M19-MEL |
GI50 |
20892.96 |
nM |
None |
| Homo sapiens |
Malme-3M |
GI50 |
17498.47 |
nM |
None |
| Homo sapiens |
MAP kinase ERK1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK1 |
Ki |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK2 |
Ki |
nan |
None |
None |
| Homo sapiens |
MAP kinase ERK2 |
Potency |
7943.3 |
nM |
None |
| Homo sapiens |
MAP kinase p38 alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
MAP kinase p38 alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase-1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase-1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase 9 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Matrix metalloproteinase 9 |
Ki |
nan |
None |
None |
| Homo sapiens |
MCF7 |
FC |
3.9 |
None |
10.1021/np500762w |
| Homo sapiens |
MCF7 |
FC |
11.0 |
None |
10.1021/acs.jnatprod.6b00782 |
| Homo sapiens |
MCF7 |
FC |
15.7 |
None |
10.1021/np300739y |
| Homo sapiens |
MCF7 |
FC |
15.7 |
None |
10.1021/np500762w |
| Homo sapiens |
MCF7 |
FC |
27.6 |
None |
10.1021/np500762w |
| Homo sapiens |
MCF7 |
IC50 |
0.003 |
ug.mL-1 |
10.1021/np500762w |
| Homo sapiens |
MCF7 |
IC50 |
0.037 |
ug.mL-1 |
10.1021/np500762w |
| Homo sapiens |
MCF7 |
IC50 |
0.31 |
ug.mL-1 |
10.1021/np500762w |
| Homo sapiens |
MCF7 |
Inhibition |
38.0 |
% |
10.1021/np200864m |
| Homo sapiens |
Melanocortin receptor 3 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Melanocortin receptor 3 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 3 |
Ki |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 4 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Melanocortin receptor 4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Melanocortin receptor 5 |
Ki |
nan |
None |
None |
| Homo sapiens |
Menin/Histone-lysine N-methyltransferase MLL |
Potency |
12589.3 |
nM |
None |
| Homo sapiens |
Microtubule-associated protein tau |
Potency |
12589.3 |
nM |
None |
| Homo sapiens |
Microtubule-associated protein tau |
Potency |
14125.4 |
nM |
None |
| Homo sapiens |
MOLT-4 |
GI50 |
7194.49 |
nM |
None |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Monoamine oxidase A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Monoamine oxidase A |
Ki |
nan |
None |
None |
| Homo sapiens |
Motilin receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
M-phase phosphoprotein 8 |
Potency |
19952.6 |
nM |
None |
| Homo sapiens |
M-phase phosphoprotein 8 |
Potency |
37685.8 |
nM |
None |
| Homo sapiens |
MRC5 |
GI50 |
14700.0 |
nM |
10.1016/j.ejmech.2018.03.028 |
| Homo sapiens |
Multidrug resistance-associated protein 4 |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
3766.3 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Mu opioid receptor |
IC50 |
4152.0 |
nM |
None |
| Homo sapiens |
Mu opioid receptor |
Ki |
1686.0 |
nM |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M4 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M4 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M5 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Muscarinic acetylcholine receptor M5 |
Ki |
nan |
None |
None |
| Homo sapiens |
Muscleblind-like protein 1 |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
NCI-H226 |
GI50 |
19633.6 |
nM |
None |
| Homo sapiens |
NCI-H23 |
GI50 |
18071.74 |
nM |
None |
| Homo sapiens |
NCI-H322M |
GI50 |
22181.96 |
nM |
None |
| Homo sapiens |
NCI-H460 |
GI50 |
18923.44 |
nM |
None |
| Homo sapiens |
NCI-H522 |
GI50 |
17864.88 |
nM |
None |
| Homo sapiens |
Neurokinin 1 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neurokinin 1 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Neurokinin 2 receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neurokinin 2 receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Neuronal acetylcholine receptor protein alpha-4 subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide S receptor |
Potency |
10000.0 |
nM |
None |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Neuropeptide Y receptor type 2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
13617.6 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
IC50 |
nan |
None |
None |
| Homo sapiens |
Norepinephrine transporter |
Ki |
nan |
None |
None |
| Homo sapiens |
Nuclear factor erythroid 2-related factor 2 |
Potency |
25929.0 |
nM |
None |
| Homo sapiens |
Nuclear factor erythroid 2-related factor 2 |
Potency |
53080.4 |
nM |
None |
| Homo sapiens |
Nuclear factor erythroid 2-related factor 2 |
Potency |
54482.7 |
nM |
None |
| Homo sapiens |
Nuclear factor NF-kappa-B p105 subunit |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
Nuclear factor NF-kappa-B p105 subunit |
Potency |
44668.4 |
nM |
None |
| Homo sapiens |
Nuclear receptor ROR-gamma |
Potency |
37578.0 |
nM |
None |
| Homo sapiens |
OVCAR-3 |
GI50 |
18323.14 |
nM |
None |
| Homo sapiens |
OVCAR-4 |
GI50 |
12735.03 |
nM |
None |
| Homo sapiens |
OVCAR-5 |
GI50 |
38018.94 |
nM |
None |
| Homo sapiens |
OVCAR-8 |
GI50 |
19633.6 |
nM |
None |
| Homo sapiens |
Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 |
Potency |
23934.1 |
nM |
None |
| Homo sapiens |
Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 |
Potency |
50118.7 |
nM |
None |
| Homo sapiens |
Peripheral myelin protein 22 |
Potency |
47754.8 |
nM |
None |
| Homo sapiens |
Peroxisome proliferator-activated receptor delta |
Potency |
8912.5 |
nM |
None |
| Homo sapiens |
Peroxisome proliferator-activated receptor delta |
Potency |
11220.2 |
nM |
None |
| Homo sapiens |
Peroxisome proliferator-activated receptor delta |
Potency |
22387.2 |
nM |
None |
| Homo sapiens |
Peroxisome proliferator-activated receptor delta |
Potency |
35481.3 |
nM |
None |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
Potency |
14125.4 |
nM |
None |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
Potency |
28183.8 |
nM |
None |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
P-glycoprotein 1 |
Activity |
nan |
None |
10.1016/j.bbrc.2004.01.156 |
| Homo sapiens |
P-glycoprotein 1 |
Activity |
nan |
None |
10.1074/jbc.m010173200 |
| Homo sapiens |
P-glycoprotein 1 |
Activity |
nan |
None |
None |
| Homo sapiens |
P-glycoprotein 1 |
FC |
4.4 |
None |
10.1021/np300739y |
| Homo sapiens |
P-glycoprotein 1 |
FC |
29.2 |
None |
10.1021/np300739y |
| Homo sapiens |
P-glycoprotein 1 |
Hill coefficient |
1.88 |
None |
10.1016/j.bmc.2007.07.024 |
| Homo sapiens |
P-glycoprotein 1 |
IC50 |
500.0 |
nM |
10.1006/bbrc.2001.6000 |
| Homo sapiens |
P-glycoprotein 1 |
IC50 |
2100.0 |
nM |
10.1006/bbrc.2001.6000 |
| Homo sapiens |
P-glycoprotein 1 |
IC50 |
2600.0 |
nM |
10.1006/bbrc.2001.6000 |
| Homo sapiens |
P-glycoprotein 1 |
IC50 |
3019.95 |
nM |
10.1016/j.bmc.2007.07.024 |
| Homo sapiens |
P-glycoprotein 1 |
IC50 |
3235.94 |
nM |
10.1016/j.bmc.2007.07.024 |
| Homo sapiens |
P-glycoprotein 1 |
IC50 |
3235.94 |
nM |
10.1016/j.bmc.2008.07.034 |
| Homo sapiens |
P-glycoprotein 1 |
IC50 |
3900.0 |
nM |
10.1006/bbrc.2001.6000 |
| Homo sapiens |
P-glycoprotein 1 |
IC50 |
5300.0 |
nM |
10.1006/bbrc.2001.6000 |
| Homo sapiens |
P-glycoprotein 1 |
IC50 |
6100.0 |
nM |
10.1006/bbrc.2001.6000 |
| Homo sapiens |
P-glycoprotein 1 |
Inhibition |
nan |
% |
10.1021/np200864m |
| Homo sapiens |
P-glycoprotein 1 |
Inhibition |
nan |
% |
10.1021/np300739y |
| Homo sapiens |
P-glycoprotein 1 |
Ki |
100.0 |
nM |
10.1021/jm020941h |
| Homo sapiens |
P-glycoprotein 1 |
Ki |
970.0 |
nM |
10.1124/mol.61.5.964 |
| Homo sapiens |
P-glycoprotein 1 |
Ki |
2310.0 |
nM |
10.1023/a:1022359300826 |
| Homo sapiens |
P-glycoprotein 1 |
Ki |
11500.0 |
nM |
10.1023/a:1016140429238 |
| Homo sapiens |
P-glycoprotein 1 |
Ki |
12200.0 |
nM |
10.1124/mol.61.5.964 |
| Homo sapiens |
P-glycoprotein 1 |
% maximum response |
51.1 |
% |
None |
| Homo sapiens |
P-glycoprotein 1 |
Papp |
68.1 |
nm/s |
None |
| Homo sapiens |
P-glycoprotein 1 |
Papp |
253.0 |
nm/s |
None |
| Homo sapiens |
P-glycoprotein 1 |
Ratio_ATPase activity |
3.85 |
None |
None |
| Homo sapiens |
P-glycoprotein 1 |
Ratio_Papp |
3.71 |
None |
None |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
3000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4A |
AC50 |
3000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4D |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 5A |
IC50 |
nan |
None |
None |
| Homo sapiens |
Phosphodiesterase 5A |
Ki |
nan |
None |
None |
| Homo sapiens |
Platelet activating factor receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Platelet activating factor receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Pregnane X receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Prelamin-A/C |
Potency |
17782.8 |
nM |
None |
| Homo sapiens |
Progesterone receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Progesterone receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Protein kinase C alpha |
IC50 |
nan |
None |
None |
| Homo sapiens |
Protein kinase C alpha |
Ki |
nan |
None |
None |
| Homo sapiens |
Receptor protein-tyrosine kinase erbB-2 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Receptor protein-tyrosine kinase erbB-2 |
Ki |
nan |
None |
None |
| Homo sapiens |
Regulator of G-protein signaling 4 |
Potency |
18869.7 |
nM |
None |
| Homo sapiens |
Retinoid X receptor alpha |
Potency |
6309.6 |
nM |
None |
| Homo sapiens |
Retinoid X receptor alpha |
Potency |
7079.5 |
nM |
None |
| Homo sapiens |
Retinoid X receptor alpha |
Potency |
31622.8 |
nM |
None |
| Homo sapiens |
RPMI-8226 |
GI50 |
6902.4 |
nM |
None |
| Homo sapiens |
Runt-related transcription factor 1/Core-binding factor subunit beta |
Potency |
25118.9 |
nM |
None |
| Homo sapiens |
Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
Ki |
1000.0 |
nM |
10.1021/acs.jmedchem.8b00542 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin 3a (5-HT3a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 6 (5-HT6) receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin 6 (5-HT6) receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Serotonin transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
IC50 |
nan |
None |
None |
| Homo sapiens |
Serotonin transporter |
Ki |
nan |
None |
None |
| Homo sapiens |
SF-268 |
GI50 |
28054.34 |
nM |
None |
| Homo sapiens |
SF-295 |
GI50 |
17701.09 |
nM |
None |
| Homo sapiens |
SF-539 |
GI50 |
11614.49 |
nM |
None |
| Homo sapiens |
Sigma opioid receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Sigma opioid receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
SK-MEL-2 |
GI50 |
19275.25 |
nM |
None |
| Homo sapiens |
SK-MEL-28 |
GI50 |
10000.0 |
nM |
None |
| Homo sapiens |
SK-MEL-5 |
GI50 |
15739.83 |
nM |
None |
| Homo sapiens |
SNB-19 |
GI50 |
16218.1 |
nM |
None |
| Homo sapiens |
SNB-75 |
GI50 |
2697.74 |
nM |
None |
| Homo sapiens |
Sodium channel alpha subunits; brain (Types I, II, III) |
IC50 |
1600.0 |
nM |
10.1021/jm00381a019 |
| Homo sapiens |
Sodium channel alpha subunits; brain (Types I, II, III) |
Inhibition |
100.0 |
% |
10.1021/jm00381a019 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B1 |
Inhibition |
67.2 |
% |
10.1021/jm300212s |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B3 |
Inhibition |
25.4 |
% |
10.1021/jm300212s |
| Homo sapiens |
Solute carrier organic anion transporter family member 2B1 |
Inhibition |
72.3 |
% |
10.1021/jm300212s |
| Homo sapiens |
SR |
GI50 |
6123.5 |
nM |
None |
| Homo sapiens |
SW-620 |
GI50 |
26791.68 |
nM |
None |
| Homo sapiens |
Synaptic vesicular amine transporter |
Bmax |
0.942 |
pmol/mg |
10.1021/acs.jmedchem.8b00542 |
| Homo sapiens |
Synaptic vesicular amine transporter |
FC |
8.0 |
None |
10.1021/acs.jmedchem.8b00542 |
| Homo sapiens |
Synaptic vesicular amine transporter |
IC50 |
13.2 |
nM |
10.1021/acs.jmedchem.8b00542 |
| Homo sapiens |
Synaptic vesicular amine transporter |
IC50 |
15.5 |
nM |
10.5281/zenodo.7360403 |
| Homo sapiens |
Synaptic vesicular amine transporter |
K |
0.028 |
None |
10.1021/acs.jmedchem.8b00542 |
| Homo sapiens |
Synaptic vesicular amine transporter |
Kd |
8.0 |
nM |
10.1021/acs.jmedchem.8b00542 |
| Homo sapiens |
Synaptic vesicular amine transporter |
Ki |
5.26 |
nM |
10.1021/acs.jmedchem.8b00542 |
| Homo sapiens |
Synaptic vesicular amine transporter |
Ki |
410.0 |
nM |
10.1021/acs.jmedchem.8b00542 |
| Homo sapiens |
Synaptic vesicular amine transporter |
Ki |
630.0 |
nM |
10.1021/acs.jmedchem.8b00542 |
| Homo sapiens |
Synaptic vesicular amine transporter |
T1/2 |
3.0 |
hr |
10.1021/acs.jmedchem.8b00542 |
| Homo sapiens |
THP-1 |
CC50 |
nan |
None |
10.1021/acs.jmedchem.8b00791 |
| Homo sapiens |
Thrombin |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thrombopoietin |
Potency |
31622.8 |
nM |
None |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thromboxane-A synthase |
IC50 |
nan |
None |
None |
| Homo sapiens |
Thromboxane-A synthase |
Ki |
nan |
None |
None |
| Homo sapiens |
Thyroid hormone receptor beta-1 |
Potency |
31622.8 |
nM |
None |
| Homo sapiens |
Thyroid hormone receptor beta-1 |
Potency |
50118.7 |
nM |
None |
| Homo sapiens |
Thyroid stimulating hormone receptor |
Potency |
15848.9 |
nM |
None |
| Homo sapiens |
TK-10 |
GI50 |
17458.22 |
nM |
None |
| Homo sapiens |
Type-1 angiotensin II receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Tyrosine-protein kinase FYN |
IC50 |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase FYN |
Ki |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase LCK |
IC50 |
nan |
None |
None |
| Homo sapiens |
Tyrosine-protein kinase LCK |
Ki |
nan |
None |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
10000.0 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
16360.1 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
18356.4 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
33498.3 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
44668.4 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
56234.1 |
nM |
None |
| Homo sapiens |
U-251 |
GI50 |
14962.36 |
nM |
None |
| Homo sapiens |
UACC-257 |
GI50 |
15631.48 |
nM |
None |
| Homo sapiens |
UACC-62 |
GI50 |
13304.54 |
nM |
None |
| Homo sapiens |
Ubiquitin carboxyl-terminal hydrolase 1 |
Potency |
22387.2 |
nM |
None |
| Homo sapiens |
Ubiquitin carboxyl-terminal hydrolase 1 |
Potency |
28183.8 |
nM |
None |
| Homo sapiens |
UO-31 |
GI50 |
15100.8 |
nM |
None |
| Homo sapiens |
Vascular endothelial growth factor receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vascular endothelial growth factor receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Vascular endothelial growth factor receptor 2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vasoactive intestinal polypeptide receptor 1 |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vasoactive intestinal polypeptide receptor 1 |
Ki |
nan |
None |
None |
| Homo sapiens |
Vasopressin V1a receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vasopressin V1a receptor |
IC50 |
nan |
None |
None |
| Homo sapiens |
Vasopressin V1a receptor |
Ki |
nan |
None |
None |
| Homo sapiens |
Vasopressin V2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vesicular amine transporter 1 |
IC50 |
50.0 |
nM |
10.5281/zenodo.7360413 |
| Homo sapiens |
Vitamin D receptor |
Potency |
12589.3 |
nM |
None |
| Homo sapiens |
Vitamin D receptor |
Potency |
31622.8 |
nM |
None |
| Homo sapiens |
Vitamin D receptor |
Potency |
35481.3 |
nM |
None |
| Homo sapiens |
Vitamin D receptor |
Potency |
50118.7 |
nM |
None |
| Influenza A virus |
Nonstructural protein 1 |
Potency |
4466.8 |
nM |
None |
| Leishmania amazonensis |
Leishmania amazonensis |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Leishmania donovani |
Leishmania donovani |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Leishmania infantum |
Leishmania infantum |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Leishmania major |
Leishmania major |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Leishmania mexicana |
Leishmania mexicana |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Mus musculus |
Bile salt export pump |
Activity |
nan |
None |
None |
| Mus musculus |
Monoamine oxidase A |
Activity |
nan |
None |
10.1021/jm800656v |
| Mus musculus |
Mus musculus |
Activity |
100.0 |
% |
10.1007/s00044-007-9041-8 |
| Mus musculus |
Mus musculus |
Activity |
nan |
None |
10.1021/jm00187a001 |
| Mus musculus |
Mus musculus |
Group performance time |
9.0 |
s |
10.1021/jm00377a006 |
| Mus musculus |
Mus musculus |
TIME |
6.0 |
hr |
10.1021/jm00377a006 |
| Mus musculus |
Nitric oxide synthase, inducible |
IC50 |
nan |
None |
None |
| Mus musculus |
Nitric oxide synthase, inducible |
Ki |
nan |
None |
None |
| Mus musculus |
P-glycoprotein 1 |
Ki |
17900.0 |
nM |
10.1124/jpet.102.037549 |
| Mus musculus |
P-glycoprotein 3 |
Activity |
nan |
None |
10.1124/jpet.102.037549 |
| Mus musculus |
P-glycoprotein 3 |
Ki |
4030.0 |
nM |
10.1124/jpet.102.037549 |
| Mus musculus |
Plasma |
Ratio AUC |
1.2 |
None |
10.1124/dmd.110.034629 |
| Mus musculus |
Synaptic vesicular amine transporter |
IC50 |
1.79 |
nM |
10.1021/acs.jmedchem.8b00542 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC |
2.0 |
ug.mL-1 |
10.1128/aac.00550-09 |
| Mycobacterium tuberculosis |
Mycobacterium tuberculosis |
MIC |
nan |
None |
10.1128/aac.00550-09 |
| Mycobacterium tuberculosis variant bovis BCG |
Mycobacterium tuberculosis variant bovis BCG |
MIC |
2.0 |
ug.mL-1 |
10.1128/aac.00550-09 |
| Mycolicibacterium smegmatis |
Mycolicibacterium smegmatis |
FICI |
0.4 |
None |
10.1016/j.ejmech.2013.06.024 |
| Mycolicibacterium smegmatis |
Mycolicibacterium smegmatis |
MIC |
256.0 |
ug.mL-1 |
10.1016/j.ejmech.2013.06.024 |
| Oryctolagus cuniculus |
Angiotensin-converting enzyme |
IC50 |
nan |
None |
None |
| Oryctolagus cuniculus |
Angiotensin-converting enzyme |
Ki |
nan |
None |
None |
| Oryctolagus cuniculus |
Arachidonate 15-lipoxygenase |
IC50 |
nan |
None |
None |
| Oryctolagus cuniculus |
Arachidonate 15-lipoxygenase |
Ki |
nan |
None |
None |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
316.23 |
nM |
10.1038/nchembio.215 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
794.33 |
nM |
10.1038/nchembio.215 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
1258.93 |
nM |
10.1038/nchembio.215 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
1995.26 |
nM |
10.1038/nchembio.215 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
2511.89 |
nM |
10.1038/nchembio.215 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
928.5 |
nM |
None |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
1471.6 |
nM |
None |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
1651.1 |
nM |
None |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
4775.5 |
nM |
None |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
7568.6 |
nM |
None |
| Pneumocystis carinii |
Pneumocystis carinii |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Pseudomonas aeruginosa |
Pseudomonas aeruginosa |
GI |
nan |
None |
10.1021/jm501628s |
| Rattus norvegicus |
Aldose reductase |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Aldose reductase |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1a adrenergic receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1a adrenergic receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1b adrenergic receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Alpha-1b adrenergic receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Androgen Receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Androgen Receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Androgen Receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Cyclooxygenase-1 |
AC50 |
18800.1 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
GABA receptor alpha-1 subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Glutamate (NMDA) receptor subunit zeta 1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Glycine receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Glycine receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Insulin receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Insulin receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Muscarinic acetylcholine receptor M1 |
Potency |
5623.4 |
nM |
None |
| Rattus norvegicus |
Muscarinic acetylcholine receptor M1 |
Potency |
8912.5 |
nM |
None |
| Rattus norvegicus |
Nitric-oxide synthase, brain |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Nitric-oxide synthase, brain |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Peripheral myelin protein 22 |
Potency |
18105.6 |
nM |
None |
| Rattus norvegicus |
Rattus norvegicus |
Blood pressure |
-34.0 |
mmHg |
10.1021/jm001017v |
| Rattus norvegicus |
Rattus norvegicus |
Blood pressure |
-31.0 |
mmHg |
10.1021/jm00072a016 |
| Rattus norvegicus |
Rattus norvegicus |
Blood pressure |
-27.0 |
mmHg |
10.1021/jm001017v |
| Rattus norvegicus |
Rattus norvegicus |
Blood pressure |
-24.0 |
mmHg |
10.1021/jm00072a016 |
| Rattus norvegicus |
Rattus norvegicus |
BP |
-35.0 |
mmHg |
10.1021/jm991004l |
| Rattus norvegicus |
Rattus norvegicus |
BP |
-29.0 |
mmHg |
10.1021/jm991004l |
| Rattus norvegicus |
Rattus norvegicus |
BP |
117.0 |
mmHg |
10.1021/jm00377a006 |
| Rattus norvegicus |
Rattus norvegicus |
Change |
-32.0 |
% |
10.1016/s0960-894x(99)00569-7 |
| Rattus norvegicus |
Rattus norvegicus |
Change |
-31.0 |
% |
10.1016/s0960-894x(99)00569-7 |
| Rattus norvegicus |
Rattus norvegicus |
Change |
-22.0 |
% |
10.1016/s0960-894x(99)00569-7 |
| Rattus norvegicus |
Rattus norvegicus |
Change |
-15.0 |
% |
10.1016/s0960-894x(99)00569-7 |
| Rattus norvegicus |
Rattus norvegicus |
Change in BP |
-23.0 |
None |
10.1021/jm00377a006 |
| Rattus norvegicus |
Rattus norvegicus |
Change in BP |
-18.0 |
None |
10.1021/jm00377a006 |
| Rattus norvegicus |
Rattus norvegicus |
Change in BP |
-16.0 |
None |
10.1021/jm00377a006 |
| Rattus norvegicus |
Rattus norvegicus |
Change in BP |
-12.0 |
None |
10.1021/jm00377a006 |
| Rattus norvegicus |
Rattus norvegicus |
Change in BP |
-10.0 |
None |
10.1021/jm00377a006 |
| Rattus norvegicus |
Rattus norvegicus |
Change in BP |
-7.0 |
None |
10.1021/jm00377a006 |
| Rattus norvegicus |
Rattus norvegicus |
Change in heart rate |
-44.0 |
None |
10.1021/jm00377a006 |
| Rattus norvegicus |
Rattus norvegicus |
Change in heart rate |
-40.0 |
None |
10.1021/jm00377a006 |
| Rattus norvegicus |
Rattus norvegicus |
Change in heart rate |
-34.0 |
None |
10.1021/jm00377a006 |
| Rattus norvegicus |
Rattus norvegicus |
Change in heart rate |
-32.0 |
None |
10.1021/jm00377a006 |
| Rattus norvegicus |
Rattus norvegicus |
Change in heart rate |
-10.0 |
None |
10.1021/jm00377a006 |
| Rattus norvegicus |
Rattus norvegicus |
dp/dt |
-1580.0 |
mmHg s-1 |
10.1021/jm00072a016 |
| Rattus norvegicus |
Rattus norvegicus |
dP/dt |
-1438.0 |
mmHg s-1 |
10.1021/jm991004l |
| Rattus norvegicus |
Rattus norvegicus |
Heart rate |
-51.0 |
beats min-1 |
10.1021/jm991004l |
| Rattus norvegicus |
Rattus norvegicus |
Heart rate |
-47.0 |
beats min-1 |
10.1021/jm00072a016 |
| Rattus norvegicus |
Rattus norvegicus |
Heart rate |
364.0 |
beats min-1 |
10.1021/jm00377a006 |
| Rattus norvegicus |
Serotonin 1a (5-HT1a) receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1a (5-HT1a) receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1b (5-HT1b) receptor |
IC50 |
nan |
None |
None |
| Rattus norvegicus |
Serotonin 1b (5-HT1b) receptor |
Ki |
nan |
None |
None |
| Rattus norvegicus |
Solute carrier family 22 member 1 |
Ki |
20000.0 |
nM |
10.1038/372549a0 |
| Rattus norvegicus |
Solute carrier family 22 member 2 |
Activity |
nan |
None |
10.1074/jbc.273.47.30915 |
| Rattus norvegicus |
Synaptic vesicular amine transporter |
AC50 |
1.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Thioredoxin reductase 1, cytoplasmic |
Potency |
19952.6 |
nM |
None |
| Rattus norvegicus |
Thioredoxin reductase 1, cytoplasmic |
Potency |
44668.4 |
nM |
None |
| Rattus norvegicus |
Voltage-gated L-type calcium channel alpha-1C subunit |
AC50 |
8834.9 |
nM |
10.1038/s41467-023-40064-9 |
| Saccharomyces cerevisiae |
Saccharomyces cerevisiae |
Potency |
20596.2 |
nM |
None |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
16.08 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
21.65 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Hit score |
0.08143 |
None |
10.1101/2020.04.21.054387 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
0.79 |
% |
10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
2.65 |
% |
10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
64.21 |
% |
10.21203/rs.3.rs-23951/v1 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition index |
0.5543 |
None |
10.1101/2020.04.03.023846 |
| Severe acute respiratory syndrome-related coronavirus |
SARS-CoV |
IC50 |
3400.0 |
nM |
10.1021/acs.jmedchem.0c00626 |
| Staphylococcus aureus |
Quinolone resistance protein norA |
Activity |
1.56 |
ug ml-1 |
10.1016/j.ejmech.2018.06.013 |
| Staphylococcus aureus |
Quinolone resistance protein norA |
Activity |
4.0 |
ug ml-1 |
10.1021/jm401808n |
| Staphylococcus aureus |
Quinolone resistance protein norA |
Activity |
84.8 |
% |
10.1021/jm1003304 |
| Staphylococcus aureus |
Quinolone resistance protein norA |
Activity |
100.0 |
ug ml-1 |
10.1021/acs.jmedchem.8b00791 |
| Staphylococcus aureus |
Quinolone resistance protein norA |
FC |
2.0 |
None |
10.1016/j.bmc.2008.09.042 |
| Staphylococcus aureus |
Quinolone resistance protein norA |
FC |
2.0 |
None |
10.1016/j.ejmech.2010.05.006 |
| Staphylococcus aureus |
Quinolone resistance protein norA |
FC |
2.0 |
None |
10.1021/jm701623q |
| Staphylococcus aureus |
Quinolone resistance protein norA |
FC |
4.0 |
None |
10.1016/j.bmc.2008.09.042 |
| Staphylococcus aureus |
Quinolone resistance protein norA |
FC |
4.0 |
None |
10.1016/j.ejmech.2010.05.006 |
| Staphylococcus aureus |
Quinolone resistance protein norA |
FC |
4.0 |
None |
10.1016/j.ejmech.2018.03.028 |
| Staphylococcus aureus |
Quinolone resistance protein norA |
FC |
4.0 |
None |
10.1021/jm400262a |
| Staphylococcus aureus |
Quinolone resistance protein norA |
FC |
4.0 |
None |
10.1021/jm701623q |
| Staphylococcus aureus |
Quinolone resistance protein norA |
FC |
8.0 |
None |
10.1128/aac.00216-07 |
| Staphylococcus aureus |
Quinolone resistance protein norA |
FICI |
0.25 |
None |
10.1016/j.bmc.2012.05.025 |
| Staphylococcus aureus |
Quinolone resistance protein norA |
IC50 |
7000.0 |
nM |
10.1021/jm200370y |
| Staphylococcus aureus |
Quinolone resistance protein norA |
IC50 |
8000.0 |
nM |
10.1128/aac.00216-07 |
| Staphylococcus aureus |
Quinolone resistance protein norA |
IC50 |
8200.0 |
nM |
10.1016/j.bmc.2012.05.025 |
| Staphylococcus aureus |
Quinolone resistance protein norA |
IC50 |
9000.0 |
nM |
10.1016/j.bmc.2023.117187 |
| Staphylococcus aureus |
Quinolone resistance protein norA |
IC50 |
9000.0 |
nM |
10.1021/acs.jmedchem.7b00215 |
| Staphylococcus aureus |
Quinolone resistance protein norA |
IC50 |
9200.0 |
nM |
10.1016/j.ejmech.2018.06.013 |
| Staphylococcus aureus |
Quinolone resistance protein norA |
IC50 |
9200.0 |
nM |
10.1021/acs.jmedchem.8b00791 |
| Staphylococcus aureus |
Quinolone resistance protein norA |
IC50 |
9200.0 |
nM |
10.1021/jm400262a |
| Staphylococcus aureus |
Quinolone resistance protein norA |
Inhibition |
30.0 |
% |
10.1016/j.bmc.2012.05.025 |
| Staphylococcus aureus |
Quinolone resistance protein norA |
Inhibition |
48.1 |
% |
10.1016/j.bmc.2012.05.025 |
| Staphylococcus aureus |
Quinolone resistance protein norA |
Inhibition |
71.8 |
% |
10.1016/j.bmc.2012.05.025 |
| Staphylococcus aureus |
Quinolone resistance protein norA |
Inhibition |
73.0 |
% |
10.1016/j.ejmech.2015.02.056 |
| Staphylococcus aureus |
Quinolone resistance protein norA |
Inhibition |
81.0 |
% |
10.1016/j.ejmech.2008.01.042 |
| Staphylococcus aureus |
Quinolone resistance protein norA |
Inhibition |
81.6 |
% |
10.1021/jm701623q |
| Staphylococcus aureus |
Quinolone resistance protein norA |
Inhibition |
82.0 |
% |
10.1016/j.ejmech.2018.06.013 |
| Staphylococcus aureus |
Quinolone resistance protein norA |
Inhibition |
82.0 |
% |
10.1021/jm400262a |
| Staphylococcus aureus |
Quinolone resistance protein norA |
Inhibition |
83.06 |
% |
10.1016/j.bmc.2018.12.008 |
| Staphylococcus aureus |
Quinolone resistance protein norA |
Inhibition |
84.8 |
% |
10.1021/acs.jmedchem.8b00791 |
| Staphylococcus aureus |
Quinolone resistance protein norA |
Inhibition |
84.8 |
% |
10.1021/jm1011963 |
| Staphylococcus aureus |
Quinolone resistance protein norA |
Inhibition |
84.8 |
% |
10.1021/jm200370y |
| Staphylococcus aureus |
Quinolone resistance protein norA |
Inhibition |
84.8 |
% |
10.1021/jm201446h |
| Staphylococcus aureus |
Quinolone resistance protein norA |
Inhibition |
85.0 |
% |
10.1039/C2MD20101A |
| Staphylococcus aureus |
Quinolone resistance protein norA |
Inhibition |
85.1 |
% |
10.1016/j.bmc.2012.05.025 |
| Staphylococcus aureus |
Quinolone resistance protein norA |
Inhibition |
nan |
% |
10.1016/j.bmc.2018.12.008 |
| Staphylococcus aureus |
Quinolone resistance protein norA |
Inhibition |
nan |
% |
10.1021/acs.jmedchem.6b01439 |
| Staphylococcus aureus |
Quinolone resistance protein norA |
Inhibition |
nan |
% |
10.1021/acs.jmedchem.8b00791 |
| Staphylococcus aureus |
Quinolone resistance protein norA |
Inhibition |
nan |
% |
10.1021/jm200370y |
| Staphylococcus aureus |
Quinolone resistance protein norA |
Inhibition |
nan |
% |
10.1021/jm201446h |
| Staphylococcus aureus |
Quinolone resistance protein norA |
Inhibition |
nan |
% |
10.1021/jm400262a |
| Staphylococcus aureus |
Quinolone resistance protein norA |
Inhibition |
nan |
% |
10.1039/C2MD20101A |
| Staphylococcus aureus |
Quinolone resistance protein norA |
MEC |
25.0 |
ug ml-1 |
10.1016/j.bmc.2018.12.008 |
| Staphylococcus aureus |
Quinolone resistance protein norA |
MEC |
25.0 |
ug ml-1 |
10.1016/j.ejmech.2010.05.006 |
| Staphylococcus aureus |
Quinolone resistance protein norA |
MIC |
2.0 |
ug.mL-1 |
10.1016/j.bmc.2008.05.030 |
| Staphylococcus aureus |
Quinolone resistance protein norA |
MIC |
4.0 |
ug.mL-1 |
10.1016/j.bmc.2008.05.030 |
| Staphylococcus aureus |
Quinolone resistance protein norA |
MMC |
6.57 |
uM |
10.1016/j.ejmech.2015.02.056 |
| Staphylococcus aureus |
Staphylococcus aureus |
Activity |
10.0 |
% |
10.1128/aac.01306-05 |
| Staphylococcus aureus |
Staphylococcus aureus |
Activity |
32.9 |
uM |
10.1016/j.ejmech.2018.03.028 |
| Staphylococcus aureus |
Staphylococcus aureus |
Activity |
40.0 |
% |
10.1128/aac.01306-05 |
| Staphylococcus aureus |
Staphylococcus aureus |
Activity |
72.0 |
% |
10.1016/j.bmc.2007.04.023 |
| Staphylococcus aureus |
Staphylococcus aureus |
Activity |
54056.0 |
None |
10.1016/j.ejmech.2022.114391 |
| Staphylococcus aureus |
Staphylococcus aureus |
Activity |
101532.7 |
None |
10.1016/j.ejmech.2022.114391 |
| Staphylococcus aureus |
Staphylococcus aureus |
Activity |
nan |
None |
10.1021/acs.jmedchem.8b00791 |
| Staphylococcus aureus |
Staphylococcus aureus |
Activity |
nan |
None |
10.1021/jm200370y |
| Staphylococcus aureus |
Staphylococcus aureus |
Activity |
nan |
None |
10.1021/jm400262a |
| Staphylococcus aureus |
Staphylococcus aureus |
Activity |
nan |
None |
10.1039/C2MD20101A |
| Staphylococcus aureus |
Staphylococcus aureus |
Concentration |
20.0 |
ug ml-1 |
10.1016/j.bmcl.2004.04.018 |
| Staphylococcus aureus |
Staphylococcus aureus |
Drug uptake |
270.0 |
ng/mg |
10.1128/aac.01306-05 |
| Staphylococcus aureus |
Staphylococcus aureus |
Drug uptake |
400.0 |
ng/mg |
10.1128/aac.01306-05 |
| Staphylococcus aureus |
Staphylococcus aureus |
FC |
0.0 |
None |
10.1007/s00044-012-0401-7 |
| Staphylococcus aureus |
Staphylococcus aureus |
FC |
0.0 |
None |
10.1016/j.bmc.2018.12.008 |
| Staphylococcus aureus |
Staphylococcus aureus |
FC |
2.0 |
None |
10.1016/j.bmc.2018.12.008 |
| Staphylococcus aureus |
Staphylococcus aureus |
FC |
2.0 |
None |
10.1016/j.ejmech.2018.03.028 |
| Staphylococcus aureus |
Staphylococcus aureus |
FC |
2.0 |
None |
10.1021/acs.jnatprod.9b01006 |
| Staphylococcus aureus |
Staphylococcus aureus |
GI |
nan |
None |
10.1016/j.bmc.2018.12.008 |
| Staphylococcus aureus |
Staphylococcus aureus |
Inhibition |
22.29 |
% |
10.1016/j.bmcl.2022.128743 |
| Staphylococcus aureus |
Staphylococcus aureus |
Inhibition |
72.1 |
% |
10.1016/j.bmcl.2022.128743 |
| Staphylococcus aureus |
Staphylococcus aureus |
Inhibition |
nan |
% |
10.1021/acs.jnatprod.9b01006 |
| Staphylococcus aureus |
Staphylococcus aureus |
IZ |
9.0 |
mm |
10.1128/aac.01306-05 |
| Staphylococcus aureus |
Staphylococcus aureus |
IZ |
12.0 |
mm |
10.1128/aac.01306-05 |
| Staphylococcus aureus |
Staphylococcus aureus |
IZ |
13.0 |
mm |
10.1128/aac.01306-05 |
| Staphylococcus aureus |
Staphylococcus aureus |
IZ |
16.0 |
mm |
10.1128/aac.01306-05 |
| Staphylococcus aureus |
Staphylococcus aureus |
IZ |
18.0 |
mm |
10.1128/aac.01306-05 |
| Staphylococcus aureus |
Staphylococcus aureus |
IZ |
19.0 |
mm |
10.1128/aac.01306-05 |
| Staphylococcus aureus |
Staphylococcus aureus |
IZ |
20.0 |
mm |
10.1128/aac.01306-05 |
| Staphylococcus aureus |
Staphylococcus aureus |
IZ |
21.0 |
mm |
10.1128/aac.01306-05 |
| Staphylococcus aureus |
Staphylococcus aureus |
IZ |
22.0 |
mm |
10.1128/aac.01306-05 |
| Staphylococcus aureus |
Staphylococcus aureus |
IZ |
24.0 |
mm |
10.1128/aac.01306-05 |
| Staphylococcus aureus |
Staphylococcus aureus |
IZ |
25.0 |
mm |
10.1128/aac.01306-05 |
| Staphylococcus aureus |
Staphylococcus aureus |
IZ |
27.0 |
mm |
10.1128/aac.01306-05 |
| Staphylococcus aureus |
Staphylococcus aureus |
IZ |
28.0 |
mm |
10.1128/aac.01306-05 |
| Staphylococcus aureus |
Staphylococcus aureus |
MEC |
25.0 |
ug ml-1 |
10.1007/s00044-012-0401-7 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
1.0 |
ug.mL-1 |
10.1128/aac.01306-05 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
8.0 |
ug.mL-1 |
10.1128/aac.01306-05 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
16.0 |
ug.mL-1 |
10.1021/acs.jnatprod.9b01006 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
64.0 |
ug.mL-1 |
10.1021/acs.jnatprod.9b01006 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
64.0 |
ug.mL-1 |
10.1021/jm401808n |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
100.0 |
ug.mL-1 |
10.1016/j.ejmech.2018.06.013 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
100.0 |
ug.mL-1 |
10.1021/acs.jmedchem.8b00791 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
100.0 |
ug.mL-1 |
10.1021/jm200370y |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
100.0 |
ug.mL-1 |
10.1021/jm201446h |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
100.0 |
ug.mL-1 |
10.1021/jm400262a |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
100.0 |
ug.mL-1 |
10.1039/C2MD20101A |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
128.0 |
ug.mL-1 |
10.1021/jm701623q |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
512.0 |
ug.mL-1 |
10.1128/aac.01306-05 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
33000.0 |
nM |
10.1016/j.bmcl.2006.12.059 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
150000.0 |
nM |
10.1021/jm400262a |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
164000.0 |
nM |
10.1016/j.ejmech.2018.06.013 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
164000.0 |
nM |
10.1021/acs.jmedchem.8b00791 |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
164000.0 |
nM |
10.1021/jm200370y |
| Staphylococcus aureus |
Staphylococcus aureus |
MIC |
nan |
None |
10.1021/acs.jmedchem.8b00791 |
| Streptococcus pneumoniae |
Streptococcus pneumoniae |
Activity |
nan |
None |
10.1128/aac.00391-07 |
| Streptococcus pneumoniae |
Streptococcus pneumoniae |
MIC |
64.0 |
ug.mL-1 |
10.1128/aac.01644-07 |
| Streptococcus pneumoniae |
Streptococcus pneumoniae |
MIC |
256.0 |
ug.mL-1 |
10.1128/aac.01644-07 |
| Toxoplasma gondii |
Toxoplasma gondii |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Trichomonas vaginalis |
Trichomonas vaginalis |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Trypanosoma brucei |
6-phospho-1-fructokinase |
Potency |
30131.3 |
nM |
None |
| Trypanosoma brucei |
Trypanosoma brucei |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Trypanosoma brucei brucei |
Trypanosoma brucei brucei |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Trypanosoma brucei rhodesiense |
Trypanosoma brucei rhodesiense |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| Trypanosoma cruzi |
Trypanosoma cruzi |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| None |
ADMET |
Activity |
0.5 |
mg |
10.1021/acs.jmedchem.0c00524 |
| None |
ADMET |
Papp |
2.3 |
ucm/s |
10.1124/dmd.110.034629 |
| None |
ADMET |
Papp |
2.7 |
ucm/s |
10.1124/dmd.110.034629 |
| None |
ADMET |
Papp |
3.6 |
ucm/s |
10.1124/dmd.110.034629 |
| None |
ADMET |
Papp |
3.9 |
ucm/s |
10.1124/dmd.110.034629 |
| None |
ADMET |
Ratio |
-16.0 |
None |
10.1124/dmd.110.034629 |
| None |
ADMET |
Ratio |
-5.0 |
None |
10.1124/dmd.110.034629 |
| None |
ADMET |
Ratio |
0.6 |
None |
10.1124/dmd.110.034629 |
| None |
ADMET |
Ratio |
0.7 |
None |
10.1124/dmd.110.034629 |
| None |
ADMET |
Ratio |
10.0 |
None |
10.1124/dmd.110.034629 |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1021/tx900326k |
| None |
Hepatotoxicity |
HepSE_bilirubinemia |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholecystitis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholelithiasis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cirrhosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_Combined Scores |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_elevated liver function tests |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic failure |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic necrosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatitis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatomegaly |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_jaundice |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver disease |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver fatty |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver function tests abnormal |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Molecular identity unknown |
Activity |
nan |
None |
10.1016/j.bmcl.2022.128743 |
| None |
Molecular identity unknown |
Potency |
10000.0 |
nM |
None |
| None |
Molecular identity unknown |
Potency |
35481.3 |
nM |
None |
| None |
Molecular identity unknown |
Potency |
74978.0 |
nM |
None |
| None |
Molecular identity unknown |
RFU |
0.35 |
None |
10.1016/j.bmcl.2022.128743 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (acute) |
0.0 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (animal toxicity known) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (benign tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (granulomatous hepatitis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (mechanism) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
0.0 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (time to onset) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
IC50 |
nan |
None |
10.1016/j.bmc.2010.01.068 |
| None |
NON-PROTEIN TARGET |
Potency |
281.8 |
nM |
None |
| None |
NON-PROTEIN TARGET |
Potency |
891.3 |
nM |
None |
| None |
NON-PROTEIN TARGET |
Potency |
1258.9 |
nM |
None |
| None |
NON-PROTEIN TARGET |
Potency |
1778.3 |
nM |
None |
| None |
NON-PROTEIN TARGET |
Potency |
1995.3 |
nM |
None |
| None |
NON-PROTEIN TARGET |
Potency |
2238.7 |
nM |
None |
| None |
NON-PROTEIN TARGET |
Potency |
2818.4 |
nM |
None |
| None |
NON-PROTEIN TARGET |
Ratio |
0.009 |
None |
10.1021/np960024c |
| None |
NON-PROTEIN TARGET |
Ratio |
0.02 |
None |
10.1021/np960024c |
| None |
NON-PROTEIN TARGET |
Ratio |
0.04 |
None |
10.1021/np960024c |
| None |
NON-PROTEIN TARGET |
Ratio |
0.05 |
None |
10.1021/np960024c |
| None |
NON-PROTEIN TARGET |
Ratio |
0.08 |
None |
10.1021/np960024c |
| None |
No relevant target |
Intrinsic_solubility |
-6.05 |
None |
10.1021/jm701623q |
| None |
No relevant target |
LogP |
3.72 |
None |
10.1021/jm070524a |
| None |
No relevant target |
LogP |
4.0 |
None |
10.1021/jm701623q |
| None |
No relevant target |
pKa |
6.6 |
None |
10.1021/jm070524a |
| None |
No relevant target |
pKa |
7.25 |
None |
10.1021/jm020941h |
| None |
No relevant target |
Solubility |
5000.0 |
nM |
10.1021/acs.jmedchem.7b01537 |
| None |
No relevant target |
Solubility |
10000.0 |
nM |
10.1021/acsmedchemlett.1c00328 |
| None |
No relevant target |
Solubility |
15600.0 |
nM |
10.1016/j.ejmech.2014.02.003 |
| None |
No relevant target |
Solubility |
15600.0 |
nM |
10.1016/j.ejmech.2015.06.031 |
| None |
No relevant target |
Solubility |
31300.0 |
nM |
10.1021/acs.jmedchem.6b00233 |
| None |
No relevant target |
Solubility |
31300.0 |
nM |
10.1021/acs.jmedchem.7b00392 |
| None |
No relevant target |
Solubility |
31300.0 |
nM |
10.1021/jm401905m |
| None |
Unchecked |
Ac50 |
7.943 |
uM |
None |
| None |
Unchecked |
Ac50 |
12.59 |
uM |
None |
| None |
Unchecked |
Ac50 |
25.12 |
uM |
None |
| None |
Unchecked |
Ac50 |
28.18 |
uM |
None |
| None |
Unchecked |
Ac50 |
31.62 |
uM |
None |
| None |
Unchecked |
AC50 |
7943.3 |
nM |
None |
| None |
Unchecked |
AC50 |
12589.3 |
nM |
None |
| None |
Unchecked |
AC50 |
25118.9 |
nM |
None |
| None |
Unchecked |
AC50 |
28183.8 |
nM |
None |
| None |
Unchecked |
AC50 |
28190.0 |
nM |
None |
| None |
Unchecked |
AC50 |
31622.8 |
nM |
None |
| None |
Unchecked |
Activity |
0.3 |
None |
10.1016/j.ejmech.2022.114391 |
| None |
Unchecked |
Activity |
0.96 |
None |
10.1016/j.ejmech.2022.114391 |
| None |
Unchecked |
Activity |
1.0 |
ug ml-1 |
10.1128/aac.01644-07 |
| None |
Unchecked |
Activity |
24.6 |
% |
10.1128/aac.01644-07 |
| None |
Unchecked |
Activity |
26.7 |
% |
10.1128/aac.01644-07 |
| None |
Unchecked |
Activity |
32.9 |
% |
10.1128/aac.01644-07 |
| None |
Unchecked |
Activity |
79.2 |
% |
10.1021/np960024c |
| None |
Unchecked |
Activity |
nan |
None |
10.1016/j.bmcl.2022.128743 |
| None |
Unchecked |
Activity |
nan |
None |
10.1016/j.ejmech.2013.06.024 |
| None |
Unchecked |
Activity |
nan |
None |
10.1021/np960024c |
| None |
Unchecked |
Activity |
nan |
None |
10.1128/aac.00391-07 |
| None |
Unchecked |
Activity ratio |
0.08 |
None |
10.1021/jm00377a006 |
| None |
Unchecked |
FC |
0.0 |
None |
10.1128/aac.00216-07 |
| None |
Unchecked |
FC |
0.758 |
None |
10.1016/j.bmc.2019.05.025 |
| None |
Unchecked |
FC |
1.3 |
None |
10.1128/aac.00853-09 |
| None |
Unchecked |
FC |
1.388 |
None |
10.1016/j.bmc.2019.05.025 |
| None |
Unchecked |
FC |
1.6 |
None |
10.1128/aac.01644-07 |
| None |
Unchecked |
FC |
2.0 |
None |
10.1128/aac.00853-09 |
| None |
Unchecked |
FC |
2.1 |
None |
10.1128/aac.01644-07 |
| None |
Unchecked |
FC |
2.3 |
None |
10.1128/aac.01644-07 |
| None |
Unchecked |
FC |
2.5 |
None |
10.1128/aac.00853-09 |
| None |
Unchecked |
FC |
2.7 |
None |
10.1128/aac.00853-09 |
| None |
Unchecked |
FC |
2.8 |
None |
10.1128/aac.01644-07 |
| None |
Unchecked |
FC |
2.9 |
None |
10.1128/aac.01644-07 |
| None |
Unchecked |
FC |
3.0 |
None |
10.1021/acs.jnatprod.6b00782 |
| None |
Unchecked |
FC |
3.3 |
None |
10.1128/aac.00853-09 |
| None |
Unchecked |
FC |
4.0 |
None |
10.1016/j.ejmech.2013.06.024 |
| None |
Unchecked |
FC |
4.0 |
None |
10.1128/aac.00216-07 |
| None |
Unchecked |
FC |
4.0 |
None |
10.1128/aac.00853-09 |
| None |
Unchecked |
FC |
4.4 |
None |
10.1021/np300414d |
| None |
Unchecked |
FC |
5.0 |
None |
10.1021/acs.jnatprod.8b00565 |
| None |
Unchecked |
FC |
15.7 |
None |
10.1021/np300414d |
| None |
Unchecked |
FC |
20.0 |
None |
10.1021/acs.jnatprod.6b00782 |
| None |
Unchecked |
FC |
29.2 |
None |
10.1021/acs.jnatprod.8b00565 |
| None |
Unchecked |
FC |
29.2 |
None |
10.1021/np300414d |
| None |
Unchecked |
Hepatotoxicity (acute) |
3.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (association with vascular disease) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (choleostasis) |
1.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (chronic liver disease) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cirrhosis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (comment) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cytolytic) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (malignant tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (severe hepatitis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (steatosis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (successful reintroduction) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
IC50 |
774.0 |
nM |
None |
| None |
Unchecked |
IC50 |
821.0 |
nM |
None |
| None |
Unchecked |
IC50 |
2050.0 |
nM |
None |
| None |
Unchecked |
IC50 |
3707.0 |
nM |
None |
| None |
Unchecked |
IC50 |
9150.0 |
nM |
10.1016/j.ejmech.2020.112359 |
| None |
Unchecked |
IC50 |
20000.0 |
nM |
10.1021/np058007n |
| None |
Unchecked |
IC50 |
nan |
None |
None |
| None |
Unchecked |
Inhibition |
32.0 |
% |
10.1016/j.ejmech.2008.01.042 |
| None |
Unchecked |
Inhibition |
nan |
% |
10.1038/nchembio873 |
| None |
Unchecked |
Ki |
528.0 |
nM |
None |
| None |
Unchecked |
Ki |
706.0 |
nM |
None |
| None |
Unchecked |
Ki |
1993.0 |
nM |
None |
| None |
Unchecked |
Ki |
3295.0 |
nM |
None |
| None |
Unchecked |
Ki |
nan |
None |
None |
| None |
Unchecked |
Potency |
163.6 |
nM |
None |
| None |
Unchecked |
Potency |
1412.5 |
nM |
None |
| None |
Unchecked |
Potency |
1835.6 |
nM |
None |
| None |
Unchecked |
Potency |
2238.7 |
nM |
None |
| None |
Unchecked |
Potency |
3548.1 |
nM |
None |
| None |
Unchecked |
Potency |
7943.3 |
nM |
None |
| None |
Unchecked |
Potency |
10318.3 |
nM |
None |
| None |
Unchecked |
Potency |
15848.9 |
nM |
None |
| None |
Unchecked |
Potency |
16360.1 |
nM |
None |
| None |
Unchecked |
Potency |
17782.8 |
nM |
None |
| None |
Unchecked |
Potency |
21131.7 |
nM |
None |
| None |
Unchecked |
Potency |
22387.2 |
nM |
None |
| None |
Unchecked |
Potency |
25118.9 |
nM |
None |
| None |
Unchecked |
Potency |
26603.2 |
nM |
None |
| None |
Unchecked |
Potency |
29092.9 |
nM |
None |
| None |
Unchecked |
Potency |
31622.8 |
nM |
None |
| None |
Unchecked |
Potency |
50118.7 |
nM |
None |
| None |
Unchecked |
Ratio |
0.0 |
None |
10.1093/toxsci/kft176 |
| None |
Unchecked |
Ratio |
7e-05 |
None |
10.1093/toxsci/kft176 |
| None |
Unchecked |
Ratio CC50/EC50 |
7.3 |
None |
10.1021/acs.jmedchem.0c00626 |
| None |
Unchecked |
Ratio ED50 |
2.0 |
None |
10.1021/np960024c |
| None |
Unchecked |
Ratio ED50 |
4.0 |
None |
10.1021/np960024c |
| None |
Unchecked |
Ratio ED50 |
8.0 |
None |
10.1021/np960024c |
| None |
Unchecked |
Ratio ED50 |
17.0 |
None |
10.1021/np960024c |
| None |
Unchecked |
Ratio ED50 |
25.0 |
None |
10.1021/np960024c |
| None |
Unchecked |
Ratio IC50 |
3.9 |
None |
10.1021/np200864m |
| None |
Unchecked |
Ratio IC50 |
15.7 |
None |
10.1021/np200864m |
| None |
Unchecked |
Ratio IC50 |
27.6 |
None |
10.1021/np200864m |
| None |
Unchecked |
RFU |
nan |
None |
10.1016/j.bmcl.2022.128743 |